How do breast cancer cells bypass the blood-brain barrier (BBB) to colonize the brain? This study uncovers a ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Programmed cell death serves as a critical defense mechanism during viral infection. The kinases RIPK1 and RIPK3, central ...

More than 40 million people worldwide are living with HIV-1, which continues to be a major global health challenge due to its ...

The FDA approved taletrectinib for ROS1-positive NSCLC. The agent shows efficacy for both new and pretreated cases, including ...

Substantial combination benefit of targeting both the ANGPT2 and VEGFA pathways has been demonstrated preclinically. Angiopoietins (ANGPTs) are ligands of the endothelial cell receptor TIE2 and ...

Researchers used a novel tool this year that successfully creates a map of the “pesticide-gut microbiota-metabolite network," ...